Neo Ivy Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q1
Sell
-6,502
Closed -$550K 350
2018
Q4
$550K Buy
+6,502
New +$550K 0.43% 102